FDA Approves Eli Lilly COVID-19 Drug Without Remdesivir

FDA Approves Eli Lilly COVID-19 Drug Without Remdesivir

Expanding on their emergency authorization from November, the FDA has granted Eli Lilly approval for the use of their COVID-19 drug baricitinib to be taken on its own and not in combination with Gilead’s drug remdesivir for patients with COVID-19. With the...
FDA Grants Second Approval for Gilead’s Trodelvy

FDA Grants Second Approval for Gilead’s Trodelvy

The U.S. Food and Drug Administration (FDA) granted accelerated approval for Trodelvy, a drug therapy for patients with locally advanced or metastatic urothelial cancer (mUC), an aggressive disease with a survival rate of 5.5%. Previously, Trodelvy was granted...